CRWV earnings
Analysis, not adviceA Technology company with about $9.9B of trailing revenue, more than double the prior year's, but it is spending heavily to build capacity: capex of roughly $27.6B against operating cash flow of $7.2B left free cash flow near -$20B, funded with about $66B of debt on only $4B of equity. The stock jumped about 25% in a day to $60.77, and the business has just tipped from a small operating profit to a roughly breakeven operating loss.
Explicit conditions that would change the desk’s view — grading follows the transcript.
CRWV is scheduled to report on 2026-11-10; FMP consensus is cons -1.27 EPS / 3.54B rev, with the earnings basis and consensus snapshot date unavailable.
+1 more — the full pre-read is on the desksign up freeThe 10 Nov 2026 print is not graded yet. It lands here once the desk has published against the transcript.
Revenue is growing about 130% year over year with a ~67% gross margin, so if the capacity build is met with sustained demand, operating leverage could return quickly.
Free cash flow is deeply negative, debt is about 16x equity, and operating margin slipped from positive to negative, leaving little cushion if growth slows or financing gets tighter.
This page shows one print. The desk has published work on 1 earlier print of CRWV.
Educational analysis, not a personalised recommendation. See all covered names on the earnings calendar · part of our public track record.